FDA Approves FENOFIBRIC ACID — Leading Pharma, LLC

Leading Pharma, LLC received FDA approval for its Fenofibric Acid via ANDA211626, a strategic development that will likely expand generic availability and intensify competition within the cholesterol-managing market segment. This authorization is expected to exert downward pressure on pricing for non-fibrate cholesterol therapies as the new product enters the commercial landscape.